Aequus Pharmaceuticals Stock Debt To Equity

Understanding the fundamental principles of building solid financial models for Aequus Pharmaceuticals is extremely important. It helps to project a fair market value of Aequus Stock properly, considering its historical fundamentals such as Debt To Equity. Since Aequus Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aequus Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aequus Pharmaceuticals' interrelated accounts and indicators.

High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

According to the company disclosure, Aequus Pharmaceuticals has a Debt To Equity of 248%. This is 363.77% higher than that of the Pharmaceuticals sector and 195.63% higher than that of the Health Care industry. The debt to equity for all Canada stocks is notably lower than that of the firm.

We derive many important indicators used in calculating different scores of Aequus Pharmaceuticals from analyzing Aequus Pharmaceuticals' financial statements. These drivers represent accounts that assess Aequus Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aequus Pharmaceuticals' important valuation drivers and their relationship over time.

The Macroaxis Fundamental Analysis modules help investors analyze Aequus Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aequus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aequus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.